(Q39407448)

English

V-AKT murine thymoma viral oncogene homolog/mammalian target of rapamycin activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis

scientific article published on 4 April 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

V-AKT murine thymoma viral oncogene homolog/mammalian target of rapamycin activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Matthias Evert

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Diego F Calvisi

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Katja Evert

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Valentina De Murtas

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Gioia Gasparetti

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sandra Mattu

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Giulia Destefanis

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sara Ladu

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Antje Zimmermann

9

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Salvatore Delogu

10

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sara Thiel

11

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Andrea Thiele

12

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Silvia Ribback

13

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Frank Dombrowski

14

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

0 references

publication date

4 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1473-1484

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Hepatocellular carcinoma arising in non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Excess risk of primary liver cancer in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Risk of cancer in patients receiving insulin glargine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Controversies in the use of insulin analogues

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Regulation of hepatic regeneration in rats by synergistic action of insulin and glucagon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Hepatocellular neoplasms induced by low-number pancreatic islet transplants in autoimmune diabetic BB/Pfd rats

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Insulin receptor, insulin receptor substrate-1, Raf-1, and Mek-1 during hormonal hepatocarcinogenesis by intrahepatic pancreatic islet transplantation in diabetic rats

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

AMPK as a metabolic tumor suppressor: control of metabolism and cell growth

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

MAPK phosphatase-3 promotes hepatic gluconeogenesis through dephosphorylation of forkhead box O1 in mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

The Akt-mTOR tango and its relevance to cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

PHLiPPing the switch on Akt and protein kinase C signaling

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

21 January 2018

Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

7 January 2021

based on heuristic

inferred from DOI database lookup

Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25600

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.25600

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39407448&oldid=1826288292"